HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in BJP Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by DAS GUPTA, R. Articles by GUEST, J. F. Search for Related Content PubMed PubMed Citation Articles by DAS GUPTA, R. Articles by GUEST, J. F.

Annual cost of bipolar disorder to UK society

CATALYST Health Economics Consultants, Northwood, Middlesex

Correspondence: Dr Julian F. Guest, CATALYST Health Economics Consultants, 34b High Street, Northwood, Middlesex HA6 IBN, UK. Tel: +44 (0) 1923 450 045; Fax: +44 (0) 1923 450 046; e-mail: jg.catalyst{at}dial.pipex.com

Declaration of interest This study was funded by a grant from Janssen-Cilag, Saunderton, UK

Background The socio-economic impact of bipolar disorder in the UK is unknown.

Aims To estimate the annual socio-economic burden imposed by bipolar disorder on UK society.

Method The annual cost of resource use attributable to managing bipolar disorder was calculated. Indirect societal costs were also calculated.

Results The annual National Health Service (NHS) cost of managing bipolar disorder was estimated to be £199 million, of which hospital admissions accounted for 35%. The annual direct non-health-care cost was estimated to be £86 million annually and the indirect societal cost was estimated to be £1770 million annually.

Conclusions The annual cost to UK society attributable to bipolar disorder was estimated to be £2 billion at 1991/2000 prices (estimated 297 000 people with the disorder). Ten per cent of this cost is attributable to NHS resource use, 4% to non-health-care resource use and 86% to indirect costs.

Related articles in BJP:

Highlights of this issue

MARY CANNON
BJP 2002 180: 0. [Full Text]  

This article has been cited by other articles:

				J. Walters and I. Jones Clinical questions and uncertainty -- prolactin measurement in patients with schizophrenia and bipolar disorder J Psychopharmacol, March 1, 2008; 22(2_suppl): 82 - 89. [Abstract] [PDF]

				J. McKendrick, K.H. Cerri, A. LLoyd, A. D'AusiLio, S. Dando, and C. Chinn Cost effectiveness of olanzapine in prevention of affective episodes in bipolar disorder in the United Kingdom J Psychopharmacol, August 1, 2007; 21(6): 588 - 596. [Abstract] [PDF]

				R. C. Kessler, H. S. Akiskal, M. Ames, H. Birnbaum, P. Greenberg, R. M .A, R. Jin, K. R. Merikangas, G. E. Simon, and P. S. Wang Prevalence and Effects of Mood Disorders on Work Performance in a Nationally Representative Sample of U.S. Workers Am J Psychiatry, September 1, 2006; 163(9): 1561 - 1568. [Abstract] [Full Text] [PDF]

				J. B. Kirkbride, P. Fearon, C. Morgan, P. Dazzan, K. Morgan, J. Tarrant, T. Lloyd, J. Holloway, G. Hutchinson, J. P. Leff, et al. Heterogeneity in Incidence Rates of Schizophrenia and Other Psychotic Syndromes: Findings From the 3-Center AeSOP Study. Arch Gen Psychiatry, March 1, 2006; 63(3): 250 - 258. [Abstract] [Full Text] [PDF]

				A. H. Young, J. Cookson, B. Elliott, J. S. E. Hellewell, R. H. McAllister-Williams, J. Newham, A. Ogilvie, J. Scott, S. Tyrer, and M. Turner Managing the aftermath of mania - Newcastle, 2 September 2005: Consensus Meeting Statement. J Psychopharmacol, March 1, 2006; 20(2 Suppl): 51 - 54. [PDF]

				D. Chisholm, M. van Ommeren, J.-L. Ayuso-Mateos, and S. Saxena Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder The British Journal of Psychiatry, December 1, 2005; 187(6): 559 - 567. [Abstract] [Full Text] [PDF]

				D. H. LAM, P. McCRONE, K. WRIGHT, and N. KERR Cost-effectiveness of relapse-prevention cognitive therapy for bipolar disorder: 30-month study The British Journal of Psychiatry, June 1, 2005; 186(6): 500 - 506. [Abstract] [Full Text] [PDF]

				S. Watson and A. H. Young Cinders, you shall go to the ball The British Journal of Psychiatry, July 1, 2003; 183 (1): 79 - 80. [Full Text] [PDF]

				S. CLEMENT, S. P. SINGH, and T. BURNS Status of bipolar disorder research: Bibliometric study The British Journal of Psychiatry, February 1, 2003; 182(2): 148 - 152. [Abstract] [Full Text] [PDF]

				Annual Costs of Bipolar Disorder in the U.K. Journal Watch Psychiatry, April 25, 2002; 2002(425): 7 - 7. [Full Text]